stars 1 stars 2 stars 3

Amoneta Diagnostics, société de biotechnologie fondée en 2014, est spécialisée dans le développement, la qualification et la commercialisation de biomarqueurs innovants pour les maladies du système nerveux central. Amoneta propose un test unique pour le diagnostic de la Maladie d’Alzheimer, s’effectuant sur un simple échantillon sanguin.

AMONETA DIAGNOSTICS Questions

The AMONETA DIAGNOSTICS annual revenue was $202000 in 2026.

Stéphanie Boutillier is the CEO of AMONETA DIAGNOSTICS.

3 people are employed at AMONETA DIAGNOSTICS.

AMONETA DIAGNOSTICS is based in Huningue, Grand Est.

The NAICS codes for AMONETA DIAGNOSTICS are [6215, 62, 62151, 621].

The SIC codes for AMONETA DIAGNOSTICS are [80, 807].

Top AMONETA DIAGNOSTICS Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users